None listed
Conditions
Interventions
Biological/Vaccine, Stem Cell : Temporary partial blocking of kidney blood flow against kidney tumor Patients who are undergoing kidney excisional surgery and are at risk of acute kidney injury after
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients =18 and <80 years of age who temporarily block the blood flow of the kidney and undergo partial renal resection for kidney tumors 2) A patient with a primary renal tumor with a diameter of 2 cm or less, clinical stage T1aN0M0 (without surrounding tissue or lymph node involvement or metastasis)
Exclusion criteria
Exclusion criteria: 1) Patients with a history of blood diseases (malignant blood diseases: acute myeloid leukemia, acute lymphoblastic leukemia, non-Hodgkin's lymphoma, Hodgkin's lymphoma, multiple myeloma) 2) Serum AST / ALT level >3 × upper limit of normal 3) Patients with a history of hypersensitivity against a gentamycin 4) Patients positive for pathogenic microorganisms (HIV, HBV, HCV, Syphilis) 5) Patients unable to compliance with protocol and follow-up 6) Patients with a history of substance abuse in the past year 7) Those who participated in other clinical trials in the past 30 days before registration. 8) Patients to be inappropriate to participate in the study according to the investigator 9) Uncontrolled hypertension or hypotension (systolic blood pressure >170 or 100 or <50 mmHg) 10) Those who being treated for severe infectious disease 11) Pregnant women, lactating women and those who disagree with contraception 12) Those who suffered or sufferring another malignant tumors excluding primary kidney tumors 13) Patients with a single kidney 14) patients with chronic kidney disease V (glomerular filtration rate <15 ml / min per 1.73 m² or during dialysis)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse event;Laboratory test;Vital sign;Physical examination | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum creatinine;Computed tomography and DTPA (Diethylene Tetramine Penta-Acetic acid) scan | — |
Countries
Korea, Republic of
Contacts
Public ContactDalsan You
Asan Medical Center
Outcome results
None listed